e-learning
resources
Berlin 2008
Monday, 06.10.2008
Donor organs and complications after lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Unexpected malignancies in explanted lungs – incidence and outcome- a single centre experience
M. A. Hoda, P. Jaksch, S. Taghavi, G. Lang, W. Klepetko (Vienna, Austria)
Source:
Annual Congress 2008 - Donor organs and complications after lung transplantation
Session:
Donor organs and complications after lung transplantation
Session type:
Thematic Poster Session
Number:
2172
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. A. Hoda, P. Jaksch, S. Taghavi, G. Lang, W. Klepetko (Vienna, Austria). Unexpected malignancies in explanted lungs – incidence and outcome- a single centre experience. Eur Respir J 2008; 32: Suppl. 52, 2172
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Investigation and outcomes of different types of biopsy in the management of peripheral lung masses – experience from a large district general hospital in the UK
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Morbidity and mortality following surgical lung biopsy in interstitial lung disease in a specialized multidisciplinary center.
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumors: a long-term single institution experience
Source: Eur Respir J 2002; 20: Suppl. 38, 270s
Year: 2002
Seasonality in airway pathogens during the first year after lung transplantation: A single center experience
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
Lung transplant outcomes in bronchiectasis –a single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Late Breaking Abstract: Comparison between referral diagnosis of patients requiring transplantation due to interstitial lung diseases and pathological diagnosis of native lungs
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
Benefits from a program for “early interstitial lung diseases” in primary care centers
Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Year: 2017
Concordance of pre transplant radiological diagnosis with posttransplant explant histology of interstitial lung disease (ILD): A single centre study from India.
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
What is the proportion of local organizing pneumonia mimicking malignancy in lung resections?
Source: International Congress 2019 – Minimally invasive thoracic surgery
Year: 2019
Primary tumours of the lung in paediatric patients
Source: Eur Respir J 2001; 18: Suppl. 33, 363s
Year: 2001
Incidence of hidden extrathoracic metastases and unexpected second malignancies detected by PET in patients with lung cancer.
Source: International Congress 2019 – Diagnosis of lung cancer
Year: 2019
Pancoast-Tobias syndrome as first clinical expression of lung cancer: its frequency among the patients of a primary care practice group in a one year survey
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007
Retrospective evaluation of children with airway and lung abnormalities: a single center experience of one year.
Source: International Congress 2019 – Insights into paediatric bronchology
Year: 2019
Spectrum of diffuse parenchymal lung diseases at a tertiary care center in India
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
Improving lung transplant outcomes in France: the high emergency lung transplantation programme
Source: Eur Respir J, 59 (1) 2102209; 10.1183/13993003.02209-2021
Year: 2022
Bronchial stenosis, a critical complication in lung transplant: single center experience
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Pediatric lung transplantation: a single center experience
Source: Eur Respir J 2006; 28: Suppl. 50, 780s
Year: 2006
Determining the perception of lung cancer screening programme amongst medical patients in single tertiary centre.
Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer
Year: 2019
Performing follow up chest x-rays for patients with a recent pneumonia leads to a significant number of other malignant and non-malignant pathologies being diagnosed.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Role of lung biopsies in the diagnosis of interstitial lung diseases in a clinical real-life setting
Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept